Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|September 17, 2001
Dual therapy for glaucoma found to be safe, effective
Memphis-Dual therapy with brimonidine (Alphagan, Allergan) andlatanoprost (Xalatan, Pharmacia & Upjohn) was more effective than timolol/dorzolamide(Cosopt, Merck) in reducing IOP in a study of 21 patients being treatedfor glaucoma. The dual therapy also produced greater clinical success asmeasured subjectively by clinicians, according to Peter A. Netland, MD,PhD.
Advertisement
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
2
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
3
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
4
Think outside the cone: The Gulani keratoconus classification
5